We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+16.75%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$683M
AUM Growth
-$142M
Cap. Flow
-$189M
Cap. Flow %
-27.61%
Top 10 Hldgs %
63.66%
Holding
120
New
21
Increased
10
Reduced
12
Closed
47

Top Buys

Rank Stock Value
1
PDCE
PDC Energy, Inc.
PDCE
+$45.1M
2
AAMI
Acadian Asset Management
AAMI
+$15.1M
3
STON
StoneMor Inc.
STON
+$11.9M
4
RNAC icon
Cartesian Therapeutics
RNAC
+$8.45M
5
CUE icon
Cue Biopharma
CUE
+$6.3M

Top Sells

Rank Stock Value
1
SRCI
SRC Energy Inc
SRCI
+$56.4M
2
VRTS icon
Virtus Investment Partners
VRTS
+$23M
3
SMTA
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
+$21.9M
4
ANIP icon
ANI Pharmaceuticals
ANIP
+$12.1M
5
FLY
Fly Leasing Limited
FLY
+$10.8M

Sector Composition

Rank Sector Weight
1 Energy 27.17%
2 Healthcare 16.58%
3 Materials 14.12%
4 Communication Services 12.28%
5 Industrials 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOMX
26
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$5.93M 0.87%
+1,779,448
New +$5.66M
CPRX
27
DELISTED
Catalyst Pharmaceutical
CPRX
$5.81M 0.85%
1,548,316
-960,522
-38% -$4.49M
GYRE icon
28
Gyre Therapeutics
GYRE
$662M
$4.65M 0.68%
91,017
-3,881
-4% -$163K
PCG icon
29
PG&E
PCG
$47.8B
$4.39M 0.64%
+403,964
New +$3.46M
DERM
30
DELISTED
Dermira, Inc.
DERM
$3.36M 0.49%
+221,640
New +$1.91M
BLU
31
DELISTED
BELLUS Health Inc.
BLU
$3.31M 0.49%
436,185
+122,336
+39% +$836K
VYNE icon
32
VYNE Therapeutics
VYNE
$340K
$3.15M 0.46%
9,432
-2,420
-20% -$807K
HCCOU
33
DELISTED
Healthcare Merger Corp. Units
HCCOU
$3.1M 0.45%
+300,000
New +$3.15M
METC icon
34
Ramaco Resources Class A
METC
$676M
$2.75M 0.4%
793,303
-6,234
-0.8% -$20.8K
SNDE
35
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$2.32M 0.34%
+121,198
New +$1.53M
LRMR icon
36
Larimar Therapeutics
LRMR
$416M
$1.97M 0.29%
148,054
– –
IMVT icon
37
Immunovant
IMVT
$8.09B
$1.59M 0.23%
100,000
– –
EGLE
38
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$1.45M 0.21%
+44,874
New +$1.38M
SPNT icon
39
SiriusPoint
SPNT
$2.98B
$1.05M 0.15%
+100,201
New +$973K
CTACW
40
DELISTED
ChaSerg Technology Acquisition Corp. Warrant
CTACW
$605K 0.09%
275,000
– –
CFFAW
41
DELISTED
CF Finance Acquisition Corp. Warrant
CFFAW
$473K 0.07%
525,000
– –
CCX.WS
42
DELISTED
Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe
CCX.WS
$403K 0.06%
283,333
– –
GRAF.WS
43
DELISTED
Graf Industrial Corp. Warrants (each exercisable for three-quarters of one share of common stock, ea
GRAF.WS
$372K 0.05%
850,000
– –
FTACW
44
DELISTED
FinTech Acquisition Corp. III Warrant
FTACW
$343K 0.05%
250,000
– –
HYACW
45
DELISTED
Haymaker Acquisition Corp. II Warrant
HYACW
$329K 0.05%
+233,333
New +$334K
ASLEW
46
DELISTED
AerSale Corp Warrants
ASLEW
$300K 0.04%
400,000
– –
CELUW
47
DELISTED
Celularity Inc
CELUW
$280K 0.04%
350,000
– –
BTRSW
48
DELISTED
BTRS Holdings Inc. Warrants
BTRSW
$225K 0.03%
+250,000
New +$214K
ADNWW
49
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$217K 0.03%
700,000
– –
IMVTW
50
DELISTED
Immunovant, Inc. Warrants expiring 12/18/2024
IMVTW
$200K 0.03%
+100,000
New +$203K
1
2
3 4 5

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Mangrove Partners held 120 positions worth $683M, down 17% from $825M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Mangrove Partners withdrew a net $189M in Q4 2019, closing 47 positions and reducing 12 holdings. Its most notable exit was SRC Energy Inc, an estimated $56.4M position sold in full.

By sector, the portfolio is most concentrated in Energy at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Mangrove Partners opened a new position in PDC Energy, Inc. worth $49.1M.

  • Mangrove Partners's largest Q4 2019 buy was PDC Energy, Inc.: 1,878,020 shares worth $49.1M.
  • Mangrove Partners added most to Acadian Asset Management in Q4 2019, an estimated $15.1M increase.
  • Mangrove Partners's biggest Q4 2019 reduction was ANI Pharmaceuticals, cutting an estimated $12.1M.
  • Mangrove Partners fully exited SRC Energy Inc in Q4 2019, selling an estimated $56.4M.
  • Mangrove Partners's ten largest holdings make up 64% of its $683M portfolio in Q4 2019.
  • Mangrove Partners opened 21 new positions and closed 47 in Q4 2019.
  • Mangrove Partners's portfolio value fell 17% quarter-over-quarter to $683M.

Based on Mangrove Partners's 13F filing for Q4 2019, filed 14 Feb 2020.